BOL-303242-X

· Bausch & Lomb Incorporated

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BOL-303242-X, covering 2020-09-03 to 2020-09-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of BOL-303242-X Versus Vehicle for the Treatment of Inflammation Following Cataract Surgery [Phase 2]